{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:59:12Z","timestamp":1790085552387,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/06397\/2025"],"award-info":[{"award-number":["UID\/06397\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031060","name":"European High Performance Computing Joint Undertaking","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009882","name":"Lombardy Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119844","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T21:04:06Z","timestamp":1786741446000},"page":"119844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a first-in-class homolog-selective, covalent NOX4 inhibitor"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0913-3219","authenticated-orcid":false,"given":"Mariana","family":"Castel\u00f4a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9722-2616","authenticated-orcid":false,"given":"Sara","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7731-7626","authenticated-orcid":false,"given":"Marta","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6257-8885","authenticated-orcid":false,"given":"F\u00e1bio G.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6560-5284","authenticated-orcid":false,"given":"S\u00e9rgio F.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Benfeito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mattevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7010-9808","authenticated-orcid":false,"given":"Daniel","family":"Chavarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2026.119844_bib1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/antiox10060890","article-title":"NADPH Oxidases (NOX): an overview from discovery, molecular mechanisms to physiology and pathology","volume":"10","author":"Vermot","year":"2021","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.biopha.2026.119844_bib2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1152\/physrev.00034.2023","article-title":"NADPH oxidases: redox regulation of cell homeostasis and disease","volume":"105","author":"Kra\u010dun","year":"2025","journal-title":"Physiol. Rev."},{"issue":"26","key":"10.1016\/j.biopha.2026.119844_bib3","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1073\/pnas.1702293114","article-title":"Crystal structures and atomic model of NADPH oxidase","volume":"114","author":"Magnani","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119844_bib4","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1021\/bi9022285","article-title":"Constitutive NADPH-Dependent Electron Transferase Activity of the Nox4 Dehydrogenase Domain","volume":"49","author":"Nisimoto","year":"2010","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.biopha.2026.119844_bib5","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/bph.13532","article-title":"Therapeutic potential of NADPH oxidase 1\/4 inhibitors","volume":"174","author":"Teixeira","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119844_bib6","series-title":"Reactive Oxygen Species: Network Pharmacology and Therapeutic Applications","first-page":"145","article-title":"NOX Inhibitors: From Bench to Naxibs to Bedside","author":"Elbatreek","year":"2021"},{"issue":"19","key":"10.1016\/j.biopha.2026.119844_bib7","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1074\/jbc.M116.768283","article-title":"NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction","volume":"292","author":"Juhasz","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119844_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.628991","article-title":"From Flies to Men: ROS and the NADPH Oxidase in Phagocytes","volume":"9","author":"Moghadam","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119844_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101234","article-title":"Tubular NOX4 expression decreases in chronic kidney disease but does not modify fibrosis evolution","volume":"26","author":"Rajaram","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119844_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101947","article-title":"NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases","volume":"41","author":"Park","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119844_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.884412","article-title":"NADPH Oxidase 4: A Potential Therapeutic Target of Malignancy","volume":"10","author":"Gong","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119844_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s13105-023-00955-3","article-title":"Structure, regulation, and physiological functions of NADPH oxidase 5 (NOX5)","volume":"79","author":"Garc\u00eda","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2026.119844_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.832314","article-title":"NADPH Oxidase 3 Deficiency Protects From Noise-Induced Sensorineural Hearing Loss","volume":"10","author":"Rousset","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119844_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3892\/br.2024.1917","article-title":"Exploring the potential regulation of DUOX in thyroid hormone\u2011autophagy signaling via IGF\u20111 in the skeletal muscle","volume":"22","author":"Then","year":"2025","journal-title":"Biomed. Rep."},{"issue":"17","key":"10.1016\/j.biopha.2026.119844_bib15","doi-asserted-by":"crossref","first-page":"11632","DOI":"10.1021\/acs.jmedchem.3c00770","article-title":"NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors","volume":"66","author":"Cipriano","year":"2023","journal-title":"J. Med. Chem."},{"issue":"31","key":"10.1016\/j.biopha.2026.119844_bib16","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1021\/bi500331y","article-title":"Nox4: A Hydrogen Peroxide-Generating Oxygen Sensor","volume":"53","author":"Nisimoto","year":"2014","journal-title":"Biochemistry"},{"issue":"15","key":"10.1016\/j.biopha.2026.119844_bib17","doi-asserted-by":"crossref","first-page":"13304","DOI":"10.1074\/jbc.M110.192138","article-title":"The E-loop Is Involved in Hydrogen Peroxide Formation by the NADPH Oxidase Nox4","volume":"286","author":"Takac","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119844_bib18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41467-017-01106-1","article-title":"NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance","volume":"8","author":"Shanmugasundaram","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119844_bib19","unstructured":"C. Therapeutics, TRANSFORM: A 24-week, Randomized, Placebo-controlled, Double-blind, Phase 2b Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Elevated Liver Stiffness, ClinicalTrials.gov. NCT Identifier: NCT05014672. Updated April 24, 2025. https:\/\/clinicaltrials.gov\/study\/NCT05014672."},{"key":"10.1016\/j.biopha.2026.119844_bib20","unstructured":"C. Therapeutics, A Phase 2, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Setanaxib, When Administered With Pembrolizumab, in Patients With Recurrent or Metastatic SCCHN, ClinicalTrials.gov. NCT Identifier: NCT05323656. Updated September 2, 2025. https:\/\/clinicaltrials.gov\/study\/NCT05323656."},{"issue":"7","key":"10.1016\/j.biopha.2026.119844_bib21","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/liv.15596","article-title":"i. the study, Setanaxib, a first-in-class selective NADPH oxidase 1\/4 inhibitor for primary biliary cholangitis: a randomized, placebo-controlled, phase 2 trial","volume":"43","author":"Invernizzi","year":"2023","journal-title":"Liver Int."},{"issue":"11","key":"10.1016\/j.biopha.2026.119844_bib22","doi-asserted-by":"crossref","first-page":"F1276","DOI":"10.1152\/ajprenal.00396.2014","article-title":"Targeting NADPH oxidase with a novel dual Nox1\/Nox4 inhibitor attenuates renal pathology in type 1 diabetes","volume":"308","author":"Gorin","year":"2015","journal-title":"Am. J. Physiol. -Ren. Physiol."},{"key":"10.1016\/j.biopha.2026.119844_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101272","article-title":"Pharmacological characterization of the seven human NOX isoforms and their inhibitors","volume":"26","author":"Augsburger","year":"2019","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119844_bib24","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1021\/acs.jmedchem.4c02644","article-title":"Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2\/MAOB Inhibitor","volume":"68","author":"Noce","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119844_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/toxsci\/kfw031","article-title":"Selective Targeting of Heme Protein in Cytochrome P450 and Nitric Oxide Synthase by Diphenyleneiodonium","volume":"151","author":"Szilagyi","year":"2016","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119844_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/HYPERTENSIONAHA.107.100214","article-title":"Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant","volume":"51","author":"Heum\u00fcller","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2026.119844_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101466","article-title":"A closer look into NADPH oxidase inhibitors: validation and insight into their mechanism of action","volume":"32","author":"Reis","year":"2020","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119844_bib28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1089\/ars.2019.7915","article-title":"The NADPH Oxidase Family and Its Inhibitors","volume":"33","author":"Chocry","year":"2019","journal-title":"Antioxid. & Redox Signal."},{"issue":"9","key":"10.1016\/j.biopha.2026.119844_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204271","article-title":"The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS. One"},{"issue":"9","key":"10.1016\/j.biopha.2026.119844_bib30","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.freeradbiomed.2012.02.046","article-title":"Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine (VAS2870)","volume":"52","author":"Sun","year":"2012","journal-title":"Free. Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.biopha.2026.119844_bib31","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1021\/acs.jmedchem.1c02134","article-title":"The Ascension of Targeted Covalent Inhibitors","volume":"65","author":"Singh","year":"2022","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119844_bib32","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","article-title":"Development of multifunctional molecules as potential therapeutic candidates for Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis in the last decade","volume":"119","author":"Savelieff","year":"2019","journal-title":"Chem. Rev."},{"issue":"13","key":"10.1016\/j.biopha.2026.119844_bib33","doi-asserted-by":"crossref","first-page":"14072","DOI":"10.1021\/acs.jmedchem.5c01272","article-title":"Enhancing Selectivity and Potency of SNAr Covalent Inhibitors of NADPH Oxidase Enzymes","volume":"68","author":"Ogboo","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119844_bib34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejpb.2017.03.001","article-title":"Opening NADPH oxidase inhibitors for in vivo translation","volume":"115","author":"Hecht","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2026.119844_bib35","unstructured":"F. Tegtmeier, U. Walter, R. Schinzel, K. Wingler, P. Scheurer, H. Schmidt, Compounds containing a N-heteroaryl moiety linked to fused ring moieties for the inhibition of NAD(P)H oxidases and platelet activation, European Patent Office, (2005) European patent No. EP1598354A1."},{"issue":"10","key":"10.1016\/j.biopha.2026.119844_bib36","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1021\/acs.jmedchem.3c01825","article-title":"Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update","volume":"67","author":"Hillebrand","year":"2024","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2026.119844_bib37","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41589-023-01457-5","article-title":"Targeting ROS production through inhibition of NADPH oxidases","volume":"19","author":"Reis","year":"2023","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119844_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40572-021-00320-w","article-title":"Mechanism of gene-environment interactions driving glial activation in Parkinson\u2019s diseases","volume":"8","author":"Sarkar","year":"2021","journal-title":"Curr. Environ. Health Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119844_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10822-024-00554-4","article-title":"Benchmarking ANI potentials as a rescoring function and screening FDA drugs for SARS-CoV-2 Mpro","volume":"38","author":"Zengin","year":"2024","journal-title":"J. Comput. -Aided Mol. Des."},{"issue":"36","key":"10.1016\/j.biopha.2026.119844_bib40","doi-asserted-by":"crossref","first-page":"41040","DOI":"10.1021\/acsomega.5c03481","article-title":"Identification of Tripeptide Inhibitors Targeting MAPK3 in Leishmania martiniquensis and Leishmania orientalis Using Molecular Modeling, Virtual Screening, Molecular Dynamics, and In Vitro Approach","volume":"10","author":"Kiriwan","year":"2025","journal-title":"ACS Omega"},{"issue":"16","key":"10.1016\/j.biopha.2026.119844_bib41","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119844_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbabio.2004.03.008","article-title":"The NADPH oxidase of professional phagocytes\u2014prototype of the NOX electron transport chain systems","volume":"1657","author":"Cross","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2026.119844_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115169","article-title":"Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease","volume":"250","author":"Tonelli","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.biopha.2026.119844_bib44","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/cssc.201600348","article-title":"Safe, Selective, and High-Yielding Synthesis of Acryloyl Chloride in a Continuous-Flow System","volume":"9","author":"Movsisyan","year":"2016","journal-title":"ChemSusChem"},{"issue":"1","key":"10.1016\/j.biopha.2026.119844_bib45","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41467-021-22924-4","article-title":"Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity","volume":"12","author":"Zhou","year":"2021","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.biopha.2026.119844_bib46","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1016\/j.polymer.2012.06.006","article-title":"Synthesis and characterization of a new polymer\u2013drug conjugate with pH-induced activity","volume":"53","author":"Chang","year":"2012","journal-title":"Polymer"},{"issue":"2","key":"10.1016\/j.biopha.2026.119844_bib47","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1093\/nar\/30.2.e9","article-title":"A. Kamen, High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells","volume":"30","author":"Durocher","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.biopha.2026.119844_bib48","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1182\/blood-2002-05-1482","article-title":"H.L. Malech, Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD\/SCID\/\u03b22-microglobulin\u2013\/\u2013 repopulating mobilized human peripheral blood CD34+ cells","volume":"102","author":"Brenner","year":"2003","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.biopha.2026.119844_bib49","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1021\/acs.jmedchem.8b00610","article-title":"Tau-Centric Multitarget Approach for Alzheimer\u2019s Disease: development of first-in-class dual glycogen synthase kinase 3\u03b2 and Tau-Aggregation Inhibitors","volume":"61","author":"Gandini","year":"2018","journal-title":"J. Med. Chem."},{"issue":"8016","key":"10.1016\/j.biopha.2026.119844_bib50","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.biopha.2026.119844_bib51","doi-asserted-by":"crossref","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: the Universal Protein Knowledgebase in 2025","volume":"53","author":"The UniProt Consortium","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.biopha.2026.119844_bib52","doi-asserted-by":"crossref","first-page":"D564","DOI":"10.1093\/nar\/gkae1091","article-title":"Updated resources for exploring experimentally-determined PDB structures and Computed Structure Models at the RCSB Protein Data Bank","volume":"53","author":"Burley","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119844_bib53","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.biopha.2026.119844_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Chemin.-."},{"issue":"1","key":"10.1016\/j.biopha.2026.119844_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1039\/D3ME00107E","article-title":"In silico identification of novel PqsD inhibitors: promising molecules for quorum sensing interference in Pseudomonas aeruginosa","volume":"9","author":"Vieira","year":"2024","journal-title":"Mol. Syst. Des. & Eng."},{"issue":"8","key":"10.1016\/j.biopha.2026.119844_bib56","doi-asserted-by":"crossref","first-page":"e00083","DOI":"10.1128\/aac.00083-22","article-title":"Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein\/ACE2 Interfaces","volume":"66","author":"Lapaillerie","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2026.119844_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103367","article-title":"Protocol for in silico characterization of natural-based molecules as quorum-sensing inhibitors","volume":"5","author":"Fernandes","year":"2024","journal-title":"STAR Protoc."},{"issue":"4","key":"10.1016\/j.biopha.2026.119844_bib58","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein\u2013ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Protein. Struct. Funct. Bioinforma."},{"issue":"1","key":"10.1016\/j.biopha.2026.119844_bib59","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1038\/s41598-025-90088-y","article-title":"silico evaluation of N-aryl-1,10-phenanthroline-2-amines as potential inhibitors of T. cruzi GP63 zinc-metalloprotease by docking and molecular dynamics simulations","volume":"15","author":"Camargo","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119844_bib60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10822-025-00622-3","article-title":"Discovery of a reversible ALDH1A3 inhibitor through a consensus docking-based virtual screening study","volume":"39","author":"Batlle","year":"2025","journal-title":"J. Comput. -Aided Mol. Des."},{"issue":"1","key":"10.1016\/j.biopha.2026.119844_bib61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13321-019-0362-7","article-title":"DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism","volume":"11","author":"Bell","year":"2019","journal-title":"J. Chemin.-."},{"issue":"9","key":"10.1016\/j.biopha.2026.119844_bib62","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2026.119844_bib63","volume":"2","author":"Frisch","year":"2009","journal-title":"Gaussian 09 Revis. A"},{"issue":"3","key":"10.1016\/j.biopha.2026.119844_bib64","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/acs.jctc.9b00953","article-title":"Split the charge difference in two! A rule of thumb for adding proper amounts of Ions in MD simulations","volume":"16","author":"Machado","year":"2020","journal-title":"J. Chem. Theory Comput."},{"issue":"1","key":"10.1016\/j.biopha.2026.119844_bib65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.biopha.2026.119844_bib66","author":"Schrodinger","year":"2020","journal-title":"PyMOL Mol. Graph. Syst."},{"issue":"7","key":"10.1016\/j.biopha.2026.119844_bib67","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"W1","key":"10.1016\/j.biopha.2026.119844_bib68","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein\u2013ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:59:14Z","timestamp":1790081954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"alternative-id":["S0753332226008802"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119844","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a first-in-class homolog-selective, covalent NOX4 inhibitor","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119844"}}